Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374803 · ClinicalTrials.gov registry record · Phase 4
Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00374803 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 45 participants.
The verdict
NCT00374803, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of a new formulation of Myfortic in combination with tacrolimus and thymoglobulin.
Interventions
- DRUG Mycophenolic Acid (Myfortic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-04 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374803
The ClinicalTrials.gov registry entry for NCT00374803 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mycophenolic Acid (Myfortic) is the first listed.
NCT00374803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374803 about?
NCT00374803 is a clinical study titled "Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal". To determine the safety and efficacy of a new formulation of Myfortic in combination with tacrolimus and thymoglobulin.
What is the current status of trial NCT00374803?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2006-04. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00374803?
The interventions under investigation include: Mycophenolic Acid (Myfortic) (DRUG).
Who is sponsoring clinical trial NCT00374803?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.